The SARS-CoV-2 Omicron BA.1 variant emerged in 2021 1 and has multiple mutations in its
spike protein 2 . Here we show that the spike protein of Omicron has a higher affinity for …

Although most mutations in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
genome are expected to be either deleterious and swiftly purged or relatively neutral, a …

A cure for HIV-1 remains unattainable as only one case has been reported, a decade ago 1
, 2 . The individual—who is known as the ‘Berlin patient’—underwent two allogeneic …

The B.1.617.2 (Delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
was first identified in the state of Maharashtra in late 2020 and spread throughout India, …

Background The emergence and spread of high levels of HIV-1 drug resistance in resource-limited
settings where combination antiretroviral treatment has been scaled up could …

The past several months have witnessed the emergence of SARS-CoV-2 variants with novel
spike protein mutations that are influencing the epidemiological and clinical aspects of the …

Background Pretreatment drug resistance in people initiating or re-initiating antiretroviral
therapy (ART) containing non-nucleoside reverse transcriptase inhibitors (NNRTIs) might …

Human cytomegalovirus (CMV) is a leading cause of congenital infections worldwide. In the
developed world, following the virtual elimination of circulating rubella, it is the commonest …

Delhi, the national capital of India, experienced multiple severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) outbreaks in 2020 and reached population seropositivity of >50…

Antiretroviral-therapy rollout in resource-poor countries is often associated with limited, if any,
HIV-RNA monitoring. The effect of variable monitoring on the emergence of resistance …